Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Dare Bioscience, Inc. | ceru-ex211_719.htm |
| EX-32.2 - EX-32.2 - Dare Bioscience, Inc. | ceru-ex322_714.htm |
| EX-31.2 - EX-31.2 - Dare Bioscience, Inc. | ceru-ex312_716.htm |
| EX-31.1 - EX-31.1 - Dare Bioscience, Inc. | ceru-ex311_717.htm |
| EX-32.1 - EX-32.1 - Dare Bioscience, Inc. | ceru-ex321_715.htm |
| EX-10.27 - EX-10.27 - Dare Bioscience, Inc. | ceru-ex1027_721.htm |
| EX-10.26 - EX-10.26 - Dare Bioscience, Inc. | ceru-ex1026_720.htm |
| 10-K - 10-K - Dare Bioscience, Inc. | ceru-10k_20151231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-198126 and No. 333-204007 on Form S-8 and No. 333-206396 on Form S-3 of our report dated March 10, 2016, relating to the consolidated financial statements of Cerulean Pharma Inc. appearing in this Annual Report on Form 10-K of Cerulean Pharma Inc. for the year ended December 31, 2015.
/s/ DELOITTE & TOUCHE LLP
Boston, Massachusetts
March 10, 2016